Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-03-02 @ 4:00 PM
Study NCT ID:
NCT06176027
Status:
RECRUITING
Last Update Posted:
2024-10-29
First Post:
2023-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas
Sponsor:
Navy General Hospital, Beijing
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-05
First Submit QC Date:
None
Study First Post Date:
2023-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-26
Last Update Post Date:
2024-10-29
Last Update Post Date Type:
ACTUAL